A Randomized Trial of Otilimab in Severe COVID-19 Pneumonia (OSCAR)
Jatin Patel(Age UK), Mark Layton(Age UK), Gerard J. Criner(Temple University Hospital), Xavier Bocca Ruiz, Mark Tidswell(Tufts University), Sofia Fernandes(Age UK), Lorrie Schifano(Research Triangle Park Foundation), Eduardo Sprinz(Hospital de Clínicas de Porto Alegre), Nicolas Terzi(Inserm), Julia E. Smith(Age UK), Gaëtan Plantefève(Centre Hospitalier Victor Dupouy), Emily Jarvis(Age UK), Timothy Hatlen(UCLA Medical Center), Charlotte Summers(University of Cambridge), Michinori Shirano(Osaka City General Hospital), Dave Inman(Age UK), Pedro Martínez-Ayala(Hospital Civil de Guadalajara), Duncan Wyncoll(Guy's and St Thomas' NHS Foundation Trust), Zainab Shahid(Memorial Sloan Kettering Cancer Center), John D. Isaacs(Newcastle upon Tyne Hospitals NHS Foundation Trust), Jessica Neisen(Age UK), Anthony Cahn(GlaxoSmithKline (United Kingdom)), Kate Hanrott(Age UK), Jean-Claude Lachérade(Roche (France)), Anubha Gupta(Indraprastha Institute of Information Technology Delhi), Rosana Muñoz-Bermúdez, Albertus Beishuizen(Medisch Spectrum Twente), R. Williamson(Age UK), Lee Schwab(Holy Cross Hospital), Bruno François(Inserm), Charlene McEvoy(Birmingham VA Medical Center), Katherine Davy(Age UK), Javier de Miguel‐Díez(Universidad Complutense de Madrid), Hatem Boughanmi(Centre Hospitalier de Valenciennes), N. E. Kostina(Voronezh Regional Clinical Oncology Center)
Cited by 27
Related Papers
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894